ORIENTAL RISE HOLDINGS Business Summary

Oriental Rise Holdings Ltd (ORIS) operates as a vertically integrated tea supplier in mainland China, generating revenue through the direct sale of tea products to wholesale distributors and retail customers. The company’s operations are divided into two primary business segments: Primarily-processed Teas, which includes initial picking and drying of white and black tea leaves, and Refined Teas, which involves advanced processing such as sifting, compressing, and packaging for end-market consumption. ORIS maintains a competitive edge by controlling the entire value chain from its tea gardens in Fujian Province to final distribution. Key direct competitors include CEA Industries (CEAD), Arcadia Biosciences (RKDA), and Laird Superfood (LSF); within this landscape, ORIS positions itself as a specialized niche player focused on the high-growth Chinese white tea market, recently expanding its footprint into the ready-to-drink beverage sector through strategic brand acquisitions. The company is led by Chairman and CEO Dezhi Liu, who has headed the organization since 2011 and brings extensive financial expertise from his previous tenure at the Agricultural Bank of China. Supporting the executive suite is CFO Bangjie Hu, appointed in May 2023, whose background includes investment management at Alpha Management Consulting and cost accounting for SSE-listed United Winners Laser. The founding team includes Chun Sun Wong, Dr. Deming Zhou, and Wai Kwong Fong, while the board features experienced directors such as Zhuo Wang and Kenneth Kei Biu Cheng, who provide oversight in audit and corporate governance. Notable institutional backing includes positions held by UBS Group AG and Barclays Capital, reflecting a degree of international investor interest as the company maintains its listing on the Nasdaq Capital Market.